Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.

This massive reach explains why so many experts consider the web the single most influential invention of modern times. In ...

Synthego, a recognized leader in CRISPR solutions, announces its formal entry into the molecular and clinical diagnostic reagents sector. Building upon its reputation for rigorous quality, custom ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Scientists are testing CRISPR gene editing as a potential HIV cure after successfully removing the virus from infected cells ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.

Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...

Discover how heat resistant materials and material science innovations help electronics manufacturing manage rising temperatures, boost reliability, and enable smaller, more powerful next‑generation ...

(Nanowerk Spotlight) As we close the final chapter of 2025, this Nanowerk Spotlight article marks a significant milestone in our coverage. We find ourselves standing at the midpoint of the decade: the ...

This article was produced in partnership with Regeneron by Scientific American Custom Media, a division separate from the magazine’s board of editors. In the long-running quest to improve on ...